Ipilimumab + nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Pancreatic Cancer.

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...

The approval was based on data from the randomized, placebo-controlled, double-blind, phase 3 RATIONALE-305 trial.

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...